Compare · MO vs UPXI
MO vs UPXI
Side-by-side comparison of Altria Group Inc. (MO) and Upexi Inc. (UPXI): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MO and UPXI operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- MO is the larger of the two at $113.66B, about 1419.6x UPXI ($80.1M).
- Over the past year, MO is up 4.0% and UPXI is down 87.7% - MO leads by 91.7 points.
- MO has hit the wire 2 times in the past 4 weeks while UPXI has been quiet.
- MO has more recent analyst coverage (21 ratings vs 2 for UPXI).
- Company
- Altria Group Inc.
- Upexi Inc.
- Price
- $69.13+1.53%
- $1.05-2.76%
- Market cap
- $113.66B
- $80.1M
- 1M return
- -7.57%
- +18.57%
- 1Y return
- +4.04%
- -87.67%
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NYSE
- NASDAQ
- IPO
- 2021
- News (4w)
- 2
- 0
- Recent ratings
- 21
- 2
Altria Group Inc.
Altria Group, Inc., through its subsidiaries, manufactures and sells cigarettes, oral tobacco products, and wine in the United States. It offers cigarettes primarily under the Marlboro brand; cigars principally under the Black & Mild brand; and moist smokeless tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands, as well as provides on! oral nicotine pouches. The company also produces and sells varietal and blended table wines, and sparkling wines under the Chateau Ste. Michelle and 14 Hands names; and imports and markets Antinori, Torres, and Villa Maria Estate wines, as well as Champagne Nicolas Feuillatte in the United States. In addition, it provides finance leasing services primarily in transportation, power generation, real estate, and manufacturing equipment industries. The company sells its tobacco products primarily to wholesalers, including distributors; and large retail organizations, such as chain stores. Altria Group, Inc. was founded in 1822 and is headquartered in Richmond, Virginia.
Latest MO
- Altria Announces Arrangement with Philip Morris International to Enhance Operational Efficiency
- Philip Morris International Announces Contract Manufacturing Collaboration with Altria
- SEC Form 10-Q filed by Altria Group Inc.
- Altria Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Altria Reports 2026 Second-Quarter and First-Half Results; Narrows 2026 Full-Year Earnings Guidance
- Cadiz Inc. Announces CFO Succession
- BTIG Research initiated coverage on Altria
- Altria to Host Webcast of 2026 Second-Quarter and First-Half Results
- UBS reiterated coverage on Altria with a new price target
- SEC Form 11-K filed by Altria Group Inc.
Latest UPXI
- Upexi Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits
- Director Salkind Gene was granted 100,000 shares, increasing direct ownership by 46% to 318,750 units (SEC Form 4)
- Director Dugan Lawrence was granted 100,000 shares, increasing direct ownership by 86% to 216,389 units (SEC Form 4)
- Chief Strategy Officer Rudick Brian Benjamin was granted 400,000 shares, increasing direct ownership by 48% to 1,238,597 units (SEC Form 4)
- Chief Executive Officer Marshall Allan was granted 2,000,000 shares, increasing direct ownership by 49% to 6,046,261 units (SEC Form 4)
- Chief Financial Officer Norstrud Andrew James was granted 400,000 shares, increasing direct ownership by 62% to 1,049,138 units (SEC Form 4)
- SEC Form EFFECT filed by Upexi Inc.
- SEC Form 424B3 filed by Upexi Inc.
- SEC Form S-3 filed by Upexi Inc.
- Upexi Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits